Monotropein attenuates doxorubicin-induced oxidative stress, inflammation, and arrhythmia via the AKT signal pathway
Authors:
- 19 November 2022
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 638, 14-22
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imagingJournal of Controlled Release, 2018
- Treating Oxidative Stress in Heart Failure: Past, Present and FutureEuropean Journal of Heart Failure, 2018
- Targeted ablation of cardiac sympathetic neurons improves ventricular electrical remodelling in a canine model of chronic myocardial infarctionEP Europace, 2018
- Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammationBiomedicine & Pharmacotherapy, 2018
- Molecular mechanism of doxorubicin-induced cardiomyopathy – An updateEuropean Journal of Pharmacology, 2018
- Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesCardiovascular Diabetology, 2017
- The critical role of Akt in cardiovascular functionVascular Pharmacology, 2015
- Monotropein exerts protective effects against IL-1β-induced apoptosis and catabolic responses on osteoarthritis chondrocytesInternational Immunopharmacology, 2014
- The flip side of doxorubicinCancer Biology & Therapy, 2013
- The QT syndromes: long and shortThe Lancet, 2008